Technology

New Orleans-based Revolo Biotherapeutics Activates Clinical Trial and Commences Enrollment in Phase 2 Clinical Study of ‘1104 in Allergic Disease in the UK

  NEW ORLEANS/LONDON (press release) – New Orleans-based Revolo Biotherapeutics (“Revolo Bio” or the “Company”), a company developing therapies that reset the immune system to achieve superior long-term remission for patients with autoimmune and allergic diseases, announced today that a…

Cox: More Help On the Way

NEW ORLEANS – From Cox Communications: Additional resources from Cox’s central and northern Virginia regions will arrive this week to assist in restoration efforts of communities hit hard by Hurricane Ida, including St. Charles Parish and portions of Jefferson Parish.…